GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (FRA:XCY) » Definitions » Sale Of Investment

OPKO Health (FRA:XCY) Sale Of Investment : €0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is OPKO Health Sale Of Investment?

OPKO Health's sale of investment for the three months ended in Dec. 2023 was €0.0 Mil. It means OPKO Health gained €0.0 Mil from selling investments. OPKO Health's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Sep. 2023 ), OPKO Health gained the same money from selling investments in Dec. 2023 (€0.0 Mil).

OPKO Health Sale Of Investment Historical Data

The historical data trend for OPKO Health's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Sale Of Investment Chart

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 12.42 7.15 108.96 0.33

OPKO Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OPKO Health Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Sale Of Investment Related Terms

Thank you for viewing the detailed overview of OPKO Health's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

OPKO Health (FRA:XCY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (FRA:XCY) » Definitions » Sale Of Investment
Comparable Companies
LAB FLGT CSTL CDNA SERA NOTV ME LDDD STIM BDSX TSE:2309 TMO DHR IQV IDXX XSWX:LONN A MTD ICLR ILMN
Traded in Other Exchanges
OPK:USA OPK:Mexico OPK:Israel XCY:Germany
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
Website
https://www.opko.com
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

OPKO Health (FRA:XCY) Headlines

No Headlines